Gallstone gene identified
This article was originally published in Clinica
A team of European scientists has identified a gallstone gene variant that could increase the risk of developing gallstones by around 2-3 times. The researchers believe that this is the first identified gene that can indicate the risk of gallstones across the general population. The team, based at the University of Bonn in Germany, and the University Clinic of Cluj-Napoca in Romania, said that the findings could lead to more successful prevention and therapy of the condition.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.